Physician

Babak Barmar, MD

According to 2025 Medicare claims, Babak Barmar, MD (NPI: 1972667202) practices internal medicine in the Winchester, VA-WV market, with the plurality of this provider's patient population coming from Frederick, VA. This provider's primary affiliated billing organization is KIDNEY SPECIALISTS, PLLC (NPI: 1376829671; TIN: 453030096) and primary practice location at 22601-2841. Barmar is affiliated with the ACO West Virginia (ACO ID: A3563), AdvantagePoint Health Alliance - Blue Ridge, LLC (ACO ID: A4654), Sound Physicians Long Term Care Management, LLC (ACO ID: A5220), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Barmar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 588 traditional Medicare patients, billed 3,120 HCPCS/CPT codes, and received $231,201 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 2,415 prescription claims across 440 beneficiaries totaling $731,150 in drug costs, led by Xphozah (Tenapanor Hcl). 2020 DME data shows 12 claims. Open Payments data shows 17 records totaling $522. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $283,815 and ending at $231,201. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $200,169 and ending at $731,150. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	615	3,366	$283,815
2016	487	1,481	$109,920
2017	721	2,386	$182,198
2018	568	1,985	$154,810
2019	491	1,911	$144,389
2020	274	1,274	$95,540
2021	393	3,173	$238,977
2022	325	1,909	$156,588
2023	574	2,372	$204,470
2024	588	3,120	$231,201

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	280	2,122	$200,169
2016	297	1,997	$136,908
2017	363	2,289	$182,054
2018	333	2,004	$132,605
2019	263	1,048	$76,617
2020	140	385	$62,141
2021	95	343	$31,241
2022	100	395	$40,324
2023	292	1,012	$63,341
2024	440	2,415	$731,150

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	12	$1,445
2017	N/R	12	$1,506
2018	N/R	48	$3,026
2019	N/R	12	$1,660
2020	N/R	12	$1,698
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	113	129	$127
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	120	388	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	282	540	$88
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	145	498	$58
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	353	794	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xphozah	Tenapanor Hcl	18	840	$81,904
Ozempic	Semaglutide	71	2,848	$77,691
Velphoro	Sucroferric Oxyhydroxide	14	450	$28,490
Farxiga	Dapagliflozin Propanediol	15	1,350	$25,007
Cinacalcet Hcl	Cinacalcet Hcl	44	3,594	$16,138

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$522	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Babak Barmar, MD?

Tedicare shows public-source Medicare data for Babak Barmar, MD (NPI 1972667202), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Babak Barmar, MD have ACO affiliation data?

Babak Barmar, MD is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563), AdvantagePoint Health Alliance - Blue Ridge, LLC (MSSP, ACO ID A4654), Sound Physicians Long Term Care Management, LLC (MSSP, ACO ID A5220), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Babak Barmar, MD?

Babak Barmar, MD is linked to KIDNEY SPECIALISTS, PLLC (billing NPI 1376829671) in the available physician profile data.

Does Babak Barmar, MD have Open Payments data?

Babak Barmar, MD has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.